Bayer, Merck Hit In Pa. Court Over Avelox Nerve Damage

By Joe Van Acker (May 26, 2015, 4:16 PM EDT) -- Bayer Corp. and Merck & Co. Inc. downplayed the risk of permanent nerve damage posed by the antibiotic Avelox and have promoted the drug for minor conditions that can be treated with safer medications, according to a complaint filed in Pennsylvania court on Friday....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Law Firms


Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!